{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:50:38Z","timestamp":1787241038425,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ijrobp.2017.05.049","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T18:03:12Z","timestamp":1496772192000},"page":"396-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A\u00a0Propensity Score Matching Analysis"],"prefix":"10.1016","volume":"99","author":[{"given":"Jeong Eun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Sik","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8327-3439","authenticated-orcid":false,"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kijun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Yun","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsil","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Hyub","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.05.049_bib1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"issue":"5 Suppl 1","key":"10.1016\/j.ijrobp.2017.05.049_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: Worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib4","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/hep.24246","article-title":"Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas","volume":"53","author":"Golfieri","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2036.2012.05089.x","article-title":"Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma","volume":"35","author":"Kim","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ctrv.2010.07.006","article-title":"Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization","volume":"37","author":"Raoul","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"Hilgard","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.4254\/wjh.v7.i5.738","article-title":"Radioembolization with yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives","volume":"7","author":"Mosconi","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12072-014-9592-y","article-title":"Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion","volume":"9","author":"Onishi","year":"2015","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib12","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1245\/s10434-014-3652-3","article-title":"Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy","volume":"21","author":"Lee","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib13","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3349\/ymj.2014.55.6.1489","article-title":"Concurrent chemoradiotherapy shows long-term survival after conversion from locally advanced to resectable hepatocellular carcinoma","volume":"55","author":"Lee","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00432-014-1697-0","article-title":"Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma","volume":"140","author":"Yoon","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/cncr.23684","article-title":"Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis","volume":"113","author":"Han","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"3 Suppl","key":"10.1016\/j.ijrobp.2017.05.049_bib18","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib19","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib20","first-page":"1209","article-title":"Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations","volume":"47","author":"Gulec","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib21","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.3748\/wjg.v11.i46.7237","article-title":"Radiation therapy for portal venous invasion by hepatocellular carcinoma","volume":"11","author":"Nakagawa","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib22","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/cncr.21043","article-title":"Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma","volume":"103","author":"Kim","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jjco\/hyl006","article-title":"Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy","volume":"36","author":"Lin","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0360-3016(03)00434-6","article-title":"Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma","volume":"57","author":"Yamada","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib25","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib26","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1200\/JCO.2000.18.11.2210","article-title":"Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies","volume":"18","author":"Dawson","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4143\/crt.2014.276","article-title":"Clinical benefit of hepatic arterial infusion concurrent chemoradiotherapy in locally advanced hepatocellular carcinoma: A propensity score matching analysis","volume":"48","author":"Yoon","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib28","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jvir.2009.10.013","article-title":"Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma","volume":"21","author":"Kooby","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib30","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cncr.24884","article-title":"Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: A two-cohort study","volume":"116","author":"Carr","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: A comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/liv.12574","article-title":"Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: A cohort study with propensity score analysis","volume":"35","author":"Gramenzi","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jamcollsurg.2008.12.009","article-title":"Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?","volume":"208","author":"Woodall","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/02841860600897934","article-title":"Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study","volume":"45","author":"M\u00e9ndez Romero","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12094-010-0492-x","article-title":"Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma","volume":"12","author":"C\u00e1rdenes","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<50::AID-CNCR8>3.0.CO;2-I","article-title":"A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization","volume":"88","author":"Llado","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jhep.2011.07.012","article-title":"Radioembolization for hepatocellular carcinoma","volume":"56","author":"Sangro","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jrr\/rrt082","article-title":"Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy","volume":"55","author":"Choi","year":"2014","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0360-3016(97)00818-3","article-title":"Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres","volume":"40","author":"Lau","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.049_bib42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jvir.2009.05.030","article-title":"Complications following radioembolization with yttrium-90 microspheres: A comprehensive literature review","volume":"20","author":"Riaz","year":"2009","journal-title":"J Vasc Interv Radiol"},{"issue":"4\u00a0Suppl","key":"10.1016\/j.ijrobp.2017.05.049_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1200\/JCO.2017.35.4_suppl.223","article-title":"A randomized phase II study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) with DEBDOX beads as a bridge to transplant in hepatocellular carcinoma (HCC)","volume":"35","author":"Nugent","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617309872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617309872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T22:59:38Z","timestamp":1535756378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301617309872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0360301617309872"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.05.049","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A\u00a0Propensity Score Matching Analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.05.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}